What is the clinical evaluation approach for suspected pseudomembranous colitis in an older adult who develops new‑onset watery diarrhea after recent antibiotic exposure?

Clinical Evaluation of Pseudomembranous Colitis

In an older adult with new-onset watery diarrhea after recent antibiotic exposure, immediately send stool for C. difficile toxin testing (EIA for toxins A and B) and consider empirical therapy with vancomycin if severe illness is present while awaiting results. 1

Initial Clinical Assessment

Key Historical Features to Elicit

• Antibiotic exposure within the previous 4-6 weeks is the most critical risk factor, with cephalosporins, clindamycin, and ampicillin/amoxicillin being the most commonly implicated agents 1, 2
• Recent hospitalization or long-term care facility stay (>20 days increases risk significantly) 3
• Age >70 years (adjusted OR 2.7) 3, 4
• Proton pump inhibitor use (adjusted OR 4.07) 4
• Underlying malignancy (adjusted OR 1.72) 4
• Recent chemotherapy exposure 1

Clinical Presentation Spectrum

The disease ranges from mild diarrhea to life-threatening complications 1:

• Watery diarrhea (defined as >2-3 unformed stools per day that conform to container) 1
• Abdominal cramping and pain 2, 5
• Fever 2, 5
• Severe leukocytosis (≥30,000 cells/mm³) - this finding warrants strong consideration of C. difficile even without diarrhea or abdominal pain 1
• Hypoalbuminemia 2

Critical caveat: Some patients, especially postoperative cases, may present with ileus or toxic megacolon WITHOUT diarrhea as the initial manifestation 1

Diagnostic Testing Algorithm

Primary Diagnostic Approach

1. Send ONE stool sample for C. difficile testing using either:

   • EIA for toxins A and B (60-90% sensitive, 75-100% specific) 1
   • Two-step algorithm: GDH antigen screen followed by toxin EIA or NAAT for confirmation 1
   • Avoid testing toxin A alone as toxin A-negative strains account for up to 3% of cases 1

2. If first EIA specimen is negative and clinical suspicion remains high, send a second sample for repeat testing 1

3. Do NOT send stool cultures - C. difficile is part of normal GI flora in 10-30% of long-term care residents, making cultures non-specific 1

4. Avoid routine stool cultures for other enteric pathogens unless the patient was admitted with diarrhea, is HIV-infected, or an outbreak is suspected 1

When to Consider Advanced Diagnostic Modalities

Flexible Sigmoidoscopy/Colonoscopy 1:

• Reserved for cases with high clinical suspicion but negative rapid tests
• When rapid diagnosis is needed and laboratory results will be delayed
• Important limitation: Only 71% of severe cases and 23% of mild cases show pseudomembranes on direct visualization 1
• Rectal sparing occurs - pseudomembranes may be present in proximal colon while rectosigmoid appears normal 6
• Risk consideration: Increased perforation risk in fulminant colitis 1

CT Imaging 1:

• Indicated for patients with clinical manifestations of severe-complicated disease (ileus, peritonitis, toxic megacolon) 1
• Sensitivity only 52%, specificity 93% 1
• Classic findings: colonic wall thickening (>4mm), accordion sign, double-halo sign, peri-colonic stranding, ascites 1
• Not suitable for screening due to poor sensitivity 1

Point-of-Care Ultrasound 1:

• Useful for critically ill patients who cannot be transported to CT suite
• Findings: thickened colonic wall with heterogeneous echogeneity, hyperechoic pseudomembranes, free fluid in >70% of cases 1

Severity Assessment and Empirical Therapy Decision

Indicators of Severe Disease Requiring Empirical Treatment

Start empirical vancomycin therapy while awaiting test results if: 1

• Severe leukocytosis (≥30,000 cells/mm³) 1
• Signs of ileus or toxic megacolon 1
• Peritoneal signs 1
• Hemodynamic instability 1

Discontinue empirical therapy if two stool evaluations are negative using a reliable assay 1

Concurrent Management Steps

• Discontinue the offending antibiotic immediately if clinically feasible 1
• Implement strict contact precautions with soap and water handwashing (alcohol preparations do NOT inactivate C. difficile spores) 1
• Correct fluid and electrolyte abnormalities 7
• Avoid antimotility agents and antidiarrheals as they may precipitate toxic megacolon 7

Common Pitfalls to Avoid

1. Do not repeat testing once diagnosis is confirmed - this leads to false positives from asymptomatic carriage 1
2. Do not rely solely on sigmoidoscopy - isolated right-sided disease can be missed 1, 6
3. Do not assume rectal involvement - up to 29% may have rectal sparing with proximal disease 6
4. Do not test patients <12 months old due to high asymptomatic colonization rates 1
5. Do not use alcohol-based hand sanitizers alone - mechanical removal with soap and water is essential 1